Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression

This publication has 26 references indexed in Scilit:

• The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells
  Biochemical Journal, 2005
• Synergistic Cytotoxicity and Pharmacogenetics of Gemcitabine and Pemetrexed Combination in Pancreatic Cancer Cell Lines
  Clinical Cancer Research, 2004
• Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
  Cancer Cell, 2004
• Loss of Activator Protein-2α Results in Overexpression of Protease-activated Receptor-1 and Correlates with the Malignant Phenotype of Human Melanoma
  Journal of Biological Chemistry, 2003
• Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers
  British Journal of Cancer, 2003
• Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways
  Oncogene, 2002
• MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia
  American Journal of Clinical Pathology, 2002
• Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
  The EMBO Journal, 2001
• Characterization of Human Mucin Gene MUC4Promoter
  Journal of Biological Chemistry, 2001
• A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
  1996